ADAPTIVE BIOTECHNOLOGIES
Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clone-SEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. It was founded in 2009 and headquartered in Seattle, Washington.
ADAPTIVE BIOTECHNOLOGIES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2009-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.adaptivebiotech.com
Total Employee:
251+
Status:
Active
Contact:
(206) 659-0067
Email Addresses:
[email protected]
Total Funding:
406.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2015-01-07 | Sequenta | Sequenta acquired by Adaptive Biotechnologies | N/A |
Investors List
ARK Investment Management
ARK Investment Management investment in Post-IPO Equity - Adaptive Biotechnologies
EquityZen
EquityZen investment in Secondary Market - Adaptive Biotechnologies
Senator Investment Group
Senator Investment Group investment in Series F - Adaptive Biotechnologies
Tiger Management Corporation
Tiger Management Corporation investment in Series F - Adaptive Biotechnologies
Matrix Capital Management
Matrix Capital Management investment in Series F - Adaptive Biotechnologies
Rock Springs Capital
Rock Springs Capital investment in Series F - Adaptive Biotechnologies
Viking Global Investors
Viking Global Investors investment in Series D - Adaptive Biotechnologies
Viking Global Investors
Viking Global Investors investment in Series C - Adaptive Biotechnologies
Key Employee Changes
Official Site Inspections
http://www.adaptivebiotech.com Semrush global rank: 1.92 M Semrush visits lastest month: 11.28 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago